T-20 and Trimeris.
James
J S
JS
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D004352:Drug Resistance, Microbial; D015507:Drugs, Investigational; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007279:Injections, Subcutaneous; D010446:Peptide Fragments; D014481:United States; D014779:Virus Replication / Q000187:drug effects*
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D000077560:Enfuvirtide